Cheat sheet
CDR CSO Cheat Sheet
Cancer and Cancer Treatment
- 20.8% of exam
- Treatment modalities Symptom recognition Urgent escalation Functional status
Nutrition Assessment
- 33.6% of exam
- Intake and body composition PG-SGA and GLIM Requirements and social context Laboratory interpretation
Nutrition Interventions
- 28.0% of exam
- Individualised routes Refeeding precautions Monitoring and referral Care coordination
Education and Counseling
- 17.6% of exam
- Teach-back Food and supplement safety Survivorship and goals Community education
Quick Facts
- Questions 150: 125 scored + 25 pretest
- Testing 180 minutes; 20-minute tutorial extra
- Fee USD 350 examination fee
- RD Status At least 2 years
- Initial Practice 2,000 hours within preceding 5 years
- Substitutions Approved: up to 40% / 800 hours
- Retake 60 days; CDR reauthorization
- Validity 5 years; eligible pilot alternative
Irinotecan Diarrhoea Timing CA
Early
- During/shortly after infusion
- Cholinergic symptoms may occur
Late
- Usually more than 24 hours
- Dehydration or sepsis risk
- Use the oncology treatment plan
Treatment and Functional Status CA
- TNM Primary tumour, nodes, distant metastasis
- Histological Grade Differentiation; distinct from anatomical stage
- ECOG 3 Limited self-care; bed/chair >50% waking
- ECOG 4 Complete disability; no self-care
- Early Irinotecan Diarrhoea During/shortly after infusion; cholinergic symptoms
- Late Irinotecan Diarrhoea Usually >24 hours; dehydration risk
Treatment Effects and Escalation CA
- Neutropenia With Abdominal Pain Urgent assessment; no automatic PN
- Checkpoint-Inhibitor Colitis Escalate diarrhoea, bleeding and dehydration
- CAR-T Altered Alertness Urgent assessment; check swallowing safety
- Head-and-Neck Radiotherapy Monitor intake, mouth and swallowing
- Pelvic Radiotherapy Diarrhoea Assess causes, losses and tolerance
- Allogeneic HSCT Assess GVHD, toxicity and intake
GLIM: One AND One NU
- Phenotype AND etiology; assess before diagnosing
- Weight, BMI or muscle Intake/assimilation or inflammation Severity uses phenotypic criteria
Screening vs Assessment NU
Screening
- Rapid risk identification
- Triggers further evaluation
Assessment
- Characterises nutritional problems
- Supports diagnosis and care plan
- Risk is not a complete diagnosis
Assessment and Triage Pathway NU
- Screen indicates nutritional risk → Complete assessment and symptom review ( Include access and cultural context )
- PG-SGA score is ≥9 → Arrange urgent symptom/nutrition intervention ( Global category requires separate assessment )
- GLIM diagnosis is considered → Find phenotypic and etiologic evidence ( Assess all criteria )
- Weight rises despite poor intake → Examine fluid and body composition ( Weight gain can mask tissue loss )
Screening, Assessment and Cachexia NU
- Positive Screening Risk identified; comprehensive assessment follows
- PG-SGA Numerical Score ≥9 Urgent symptom and nutrition intervention
- PG-SGA Global A/B/C Separate assessment; not score bands
- GLIM Diagnosis ≥1 phenotypic AND ≥1 etiologic criterion
- Fearon: Six-Month Weight Loss >5%; assess full clinical syndrome
- Fearon Alternative >2% loss plus BMI<20 or sarcopenia
PG-SGA Score vs Global Category NU
Numerical score
- Intervention triage
- ≥9 signals urgent need
A/B/C category
- Clinical nutritional-status judgement
- Not numeric score bands
- Record score and global category separately
Weight, Muscle and Fluid NU
- Weight-Loss Percentage Lost weight ÷ usual weight ×100
- 80 kg → 74 kg 7.5% loss; interpret timeframe
- High BMI Does not exclude muscle depletion
- Muscle Thresholds Method and population must match
- Ascites/Oedema Assess fluid; no fixed-kilogram subtraction
- Albumin Inflammation-sensitive; not stand-alone nutrition diagnosis
Food Deprivation vs Cachexia NU
Food deprivation
- Insufficient nutrient supply
- Investigate access and reversible barriers
Cancer cachexia
- Intake plus metabolic disturbance
- Nutrition alone may not reverse
- Treat causes as well as intake
Biochemistry and Clinical Context NU
- Refeeding Electrolytes Track phosphorus, potassium and magnesium
- Refeeding Diagnosis Post-feeding change plus clinical context
- Tumour Lysis Pattern High potassium/phosphate/urate; low calcium
- Tumour Lysis Response Urgent team care; individualise electrolytes
- Ferritin Inflammation may mask iron deficiency
- Food Insecurity Assess access, affordability and facilities
Requirements and Assessment NU
- ESPEN Estimated Energy 25–30 kcal/kg/day; individualise
- ESPEN Protein (g/kg/day) Above 1; if possible, 1.5
- Reference Weight Assess fluid and body composition
- Gastrectomy Monitor intake, B12 and iron
- Abiraterone Food Rules Check exact formulation and label
- GLIM 2026 Intake Guidance Usual intake; symptoms and duration
Refeeding: Before, Begin, Reassess NU
- Thiamine, electrolytes, cautious calories, monitoring
- Severely low: delay and correct Count IV dextrose Advance with clinical stability
Enteral vs Parenteral Nutrition NU
EN
- Uses gastrointestinal tract
- Preferred when feasible
PN
- Intravenous nutrient delivery
- When EN is insufficient/impossible
- Individualise by function, goals and tolerance
Route Selection After Assessment NU
- Oral intake is safe and feasible → Optimise foods, symptoms and supplements ( Monitor achieved intake )
- Oral measures remain inadequate → Use enteral support when feasible ( Assess swallowing and bowel function )
- Enteral support insufficient or impossible → Consider supplemental or total PN ( Balance expected benefit and burden )
- Clinical state or goals change → Reassess route and nutrition targets ( Avoid automatic treatment duration )
Gastrointestinal Nutrition Decisions NU
- Faecal Elastase <100 μg/g Supports EPI; formed stool sample
- Faecal Elastase 100–200 μg/g Indeterminate; assess further
- Adult PERT Starting Dose ≥40,000 USP lipase units/meal
- PERT Snacks Half meal dose; take with food
- Chyle Leak Individualise fat; preserve essential fats
- High Ileostomy Output Assess hydration; specialist fluid plan
At-Risk Adult Refeeding Pathway NU
- Before feeding or IV dextrose → Give thiamine; check P/K/Mg ( ASPEN: thiamine 100 mg )
- Electrolytes are severely low → Delay initiation/increases; replace and monitor ( Individualise for renal and clinical status )
- Starting feeds with monitoring established → 10–20 kcal/kg across first day ( Count dextrose from all sources )
- Electrolytes fall precipitously → Reduce calories; treat and reassess ( Advance only with clinical stability )
Nutrition Routes and Refeeding NU
- Oral Intake Inadequate Counsel, fortify, consider supplements
- Oral Measures Insufficient Enteral nutrition when feasible
- Enteral Support Inadequate/Impossible Consider PN; assess benefit and burden
- ASPEN At-Risk Adult Thiamine 100 mg before feeding/dextrose
- ASPEN Calories: First 24 Hours 10–20 kcal/kg; include IV dextrose
- Severely Low Electrolytes Delay feeding/increases; treat and monitor
Monitoring and Team Decisions NU
- PN Monitoring Glucose, electrolytes, fluid, triglycerides, liver
- Gastrostomy Before Radiotherapy Individual risk-benefit discussion; not universal
- Symptomatic GI GVHD Choose route by function and tolerance
- Swallowing Red Flags Cough, wet voice, suspected aspiration
- Monitoring Plan Define outcomes, timing and response
- Home Enteral Coverage CMS: long and indefinite impairment
Food Safety: Four Actions ED
- Clean, Separate, Cook, Chill
- Choose safer foods Check preparation temperatures Follow transplant precautions
Laboratory Signal vs Clinical Evidence ED
Laboratory/animal
- Mechanistic signal
- May prompt precaution
Human clinical
- Patient outcomes studied
- Design and context still matter
- Laboratory results do not prove harm
Counselling and Shared Decisions ED
- Patient proposes restrictive cancer diet → Explore aims and explain evidence ( Assess risk without dismissing concerns )
- Patient uses supplements or herbs → Record product; request interaction review ( Distinguish preclinical from human evidence )
- Teaching an individual or group → Agree practical goals; use teach-back ( Adapt language, access and preferences )
- Prognosis or goals change → Discuss expected benefit and burden ( Comfort care includes mouth care )
Education, Safety and Goals ED
- Food-Safety Framework Clean, separate, cook and chill
- Immunosuppression: Deli Meats Heat to 165°F or steaming
- EGCG–Bortezomib Evidence Laboratory/animal findings; human significance uncertain
- High-Dose Antioxidants No routine recommendation during treatment
- WCRF Cooked Red Meat Limit about 350–500 g/week
- Dying Phase Prioritise comfort and individual goals
Common Traps
PG-SGA Triage versus Global Category
- Score ≥9: urgent nutrition/symptom intervention ≠ Global C: separate clinical assessment
Nutrition Route: Bowel Function Matters
- Severe GI symptoms: assess function/tolerance ≠ Automatic PN solely from symptom severity
Fluid-Affected Weight versus Fixed Subtraction
- Fluid shifts can conceal tissue loss ≠ Universal kilogram subtraction for dry-weight
Refeeding: Serial Change versus Snapshot
- After increased calories: serial electrolyte changes ≠ Diagnosis from one phosphorus cutoff
EGCG–Bortezomib: Evidence Level Matters
- EGCG–bortezomib preclinical findings ≠ Proof of human clinical antagonism
CSO Recertification: Standard versus Limited Alternative
- Standard route: examination ≠ Eligible longitudinal-assessment pilot: alternative route
Last Minute
- 1. Separate 150 total from 125 scored
- 2. Calculate weights using scored items
- 3. PG-SGA score differs from global category
- 4. GLIM requires phenotype AND etiology
- 5. Interpret weight alongside fluid and muscle
- 6. Escalate urgent oncology symptoms
- 7. Individualise energy, protein and reference weight
- 8. Choose route by function and goals
- 9. Use refeeding precautions when indicated
- 10. Review exact drug formulation and supplements
- 11. Adapt counselling to access and culture
- 12. Document outcomes and reassessment
CDR CSO Board Certified Specialist in Oncology Nutrition
- Practice Questions 147 questions Study Guide 43 topics Cheat Sheet 60 facts Flashcards 50 cards Games 20 terms Free CE Podcast
- Word games 20 terms Guess the Term T E R M S Read the clue and guess the term in 6 tries. Word games 20 terms Term Match Swap tiles to line up three of the same term. Word games 20 terms Term Pairs ? ✓ ✓ ? ? Flip two cards at a time to find matching terms. Word games 20 terms Term Search Q T E R M X Find five hidden terms in a grid of letters.